Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study

The Christie NHS Foundation Trust30 enrolled

Overview

To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from the perspective of survivors

Explore survivors' attitudes towards lung cancer and lung cancer screening Explore survivors' understanding of cancer screening as a concept and the benefits of screening and early detection Explore survivors' level of awareness of and attitudes towards their lung cancer risk Explore survivors' views on the barriers and motivating factors that would impact their decision to attend a lung cancer screening test

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hodgkin Lymphoma

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Details held in the ADAPT database at The Christie NHS Foundation trust * Responded to most recent ADAPT study questionnaire (April - August 2019) * Aged 18-80 * Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years * Able to provide informed consent * Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy. Exclusion Criteria: * Previous or current diagnosis of lung cancer * Stated within 2019 health questionnaire that they did not wish to be contacted * Have participated in lung cancer screening through the Manchester Lung Health Checks

Locations (1)

Christie NHS Foundation Trust

Manchester, United Kingdom

Outcomes

Primary Outcomes

Explore survivors' attitudes towards lung cancer and lung cancer screening

Semi-structured interviews

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.